Wayland Group Enters into Agreement to Expand Global Footprint with Acquisition in Colombia

November 06, 18

TORONTO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company) is pleased to announce that the Company has entered the South American market through a transaction in Colombia. Wayland has entered into a definitive agreement to acquire 100% of the outstanding shares of Colma Pharmaceutical SAS (“Colma”), a

Read More

Wayland Releases Portfolio of Brands & Receives Sales License from Health Canada for Expansion Site

October 17, 18

TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company“) is excited to announce the release of its portfolio of brands that cater to different ages, genders, and occasions. The Company’s extensive research created a portfolio of brands, each designed to address segments of the cannabis market both

Read More

Wayland Signs Minimum 9,000 kilograms Supply Agreement with Cannamedical for Export of Product from Canada to Germany

October 15, 18

TORONTO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) ("Wayland" or the "Company) is pleased to announce that it has entered into an agreement to supply Cannamedical Pharma GmbH, a licensed, privately owned importer and distributor of cannabis in Germany to over 2,200 pharmacies with a minimum of 9,000 kilograms of

Read More

Wayland Group Announces $50 million Bought Deal Financing

October 11, 18

TORONTO, Oct. 11, 2018 /CNW/ - Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) ("Wayland" or the "Company") announced today that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the "Lead Underwriter" and, collectively with the syndicate, the "Underwriters"), pursuant to which the Underwriters will purchase, on a bought

Read More

Wayland successfully exports THC distillate from Canada to Switzerland

October 10, 18

TORONTO, ON, OCTOBER 10, 2018 // Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company) announces the Company’s achievement of yet another international milestone as part of its global expansion plan: The Company has now exported THC distillate within a stability range that meets the standards suitable for product commercialization to Switzerland. MARICANN GROUP

Read More

Wayland Announces Plans for First Retail Location in Zurich, Switzerland

September 27, 18

Elevated retail concept set to launch in 2019 TORONTO, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company) is pleased to announce that the Company will open its first retail location in Zurich, Switzerland in 2019 - serving the market with high quality cannabis products that contain a

Read More

Announces Closing of $40 Million Private Placement

September 01, 18

Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) ("Maricann" or the "Company") is pleased to announce the closing of its previously announced private placement offering (the "Offering") of special warrants (the "Special Warrants") for aggregate gross proceeds of $40,250,000. Eight Capital, as sole bookrunner and co-lead agent with Canaccord Genuity Corp., and together with Industrial Alliance Securities Inc. (the

Read More

Upsize of Previously Announced Private Placement

December 14, 17

Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) ("Maricann" or the "Company") is pleased to announce that it has entered into an amended letter of engagement with Eight Capital, under which Eight Capital has now agreed to offer for sale, as sole bookrunner and co-lead agent with Canaccord Genuity Corp., and together with a syndicate of agents including Industrial

Read More

Announces $20 Million Private Placement

December 13, 17

Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) ("Maricann" or the "Company") is pleased to announce that it has entered into a letter of engagement with Eight Capital, pursuant to which Eight Capital, acting as sole bookrunner and co-lead agent with Canaccord Genuity Corp., has agreed to offer for sale, together with a syndicate of agents (together with Eight

Read More

Signs Definitive Agreement with Lovell Drugs for Medical Cannabis Retail Pharmacy Initiative

December 12, 17

Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) "Maricann" or the "Company") is pleased to announce that it has entered into a definitive agreement with Lovell Drugs Limited ("Lovell Drugs"), Ontario's oldest pharmacy chain, to be the exclusive provider of medical cannabis to its pharmacies. Lovell Drugs will, in partnership with Maricann, implement a medical cannabis education and access

Read More